Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial (vol 29, pg 3120, 2023)

被引：2
|
作者：
Mautner, Ken
Gottschalk, Michael
Boden, Scott D.
Akard, Alison
Bae, Won C.
Black, Lora
Boggess, Blake
Chatterjee, Paramita
Chung, Christine B.
Easley, Kirk A.
Gibson, Greg
Hackel, Josh
Jensen, Katie
Kippner, Linda
Kurtenbach, Chad
Kurtzberg, Joanne
Mason, R. Amadeus
Noonan, Benjamin
Roy, Krishnendu
Valentine, Verle
Yeago, Carolyn
Drissi, Hicham
机构：
[1] Emory University,Department of Orthopaedics
[2] University of California,Department of Radiology
[3] Davis,Marcus Center for Therapeutic Cell Characterization and Manufacturing
[4] Sanford Health,Department of Biostatistics and Bioinformatics
[5] Duke Sports Medicine,Center for Integrative Genomics
[6] Georgia Institute of Technology,Marcus Center for Therapeutic Cures
[7] Emory University,Biomedical Engineering
[8] Georgia Institute of Technology,undefined
[9] Andrews Institute,undefined
[10] Duke University,undefined
[11] Sanford Health,undefined
[12] Vanderbilt University,undefined
来源：
NATURE MEDICINE | 2024年 / 30卷 / 03期
关键词：
D O I：
10.1038/s41591-023-02776-9
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：905 / 905
页数：1
相关论文
共 50 条
  • [41] Randomized Phase II Trial of First-Line Treatment With Sorafenib Versus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma (vol 27, pg 1280, 2009)
    Escudier
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (13) : 2305 - 2305
  • [42] Hyaluronic acid versus platelet-rich plasma: a prospective, double-blind randomized controlled trial comparing clinical outcomes and effects on intra-articular biology for the treatment of knee osteoarthritis (vol 45, pg 339, 2017)
    Cole, B. J.
    Karas, V
    Hussey, K.
    Merkow, D. B.
    Pilz, K.
    Fortier, L. A.
    AMERICAN JOURNAL OF SPORTS MEDICINE, 2017, 45 (05): : NP10 - NP10
  • [43] Cognitive functional therapy with or without movement sensor biofeedback versus usual care for chronic, disabling low back pain (RESTORE): a randomised, controlled, three-arm, parallel group, phase 3, clinical trial (vol 401, pg 1866, 2023)
    Kent, P.
    Haines, T.
    O'Sullivan, P.
    LANCET, 2023, 402 (10406): : 964 - 964
  • [44] Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck Cancer (vol 116, pg 533, 2023)
    Caudell, Jj
    Torres-Saavedra, Pa
    Rosenthal, Di
    Axelrod, Rs
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (03): : 774 - 776
  • [45] Efficacy of Savolitinib vs Sunitinib in Patients With MET-Driven Papillary Renal Cell Carcinoma: The SAVOIR Phase 3 Randomized Clinical Trial (vol 6, pg 1247, 2020)
    Choueiri, T. K.
    Heng, D. Y. C.
    Lee, J. L.
    JAMA ONCOLOGY, 2020, 6 (09) : 1473 - 1473
  • [46] Celecoxib-tramadol co-crystal in patients with moderate-to-severe pain following bunionectomy with osteotomy: A phase 3, randomized, double-blind, factorial, active- and placebo-controlled trial. (Vol 23, pg 8, 2023)
    Viscusi, Eugene R.
    de Leon-Casasola, Oscar
    Cebrecos, Jesus
    Jacobs, Adam
    Morte, Adelaida
    Ortiz, Esther
    Sust, Mariano
    Vaque, Anna
    Gottlieb, Ira
    Daniels, Stephen
    Gimbel, Joseph S.
    Muse, Derek
    Winkle, Peter
    Kuss, Michael E.
    Videla, Sebastian
    Gascon, Neus
    Plata-Salaman, Carlos
    PAIN PRACTICE, 2024, 24 (07) : 969 - 970
  • [47] Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer The VIABLE Phase 3 Randomized Clinical Trial
    Vogelzang, Nicholas J.
    Beer, Tomasz M.
    Gerritsen, Winald
    Oudard, Stephane
    Wiechno, Pawel
    Kukielka-Budny, Bozena
    Samal, Vladimir
    Hajek, Jaroslav
    Feyerabend, Susan
    Khoo, Vincent
    Stenzl, Arnulf
    Csoszi, Tibor
    Filipovic, Zoran
    Goncalves, Frederico
    Prokhorov, Alexander
    Cheung, Eric
    Hussain, Arif
    Sousa, Nuno
    Bahl, Amit
    Hussain, Syed
    Fricke, Harald
    Kadlecova, Pavla
    Scheiner, Tomas
    Korolkiewicz, Roman P.
    Bartunkova, Jirina
    Spisek, Radek
    JAMA ONCOLOGY, 2022, 8 (04) : 546 - 552
  • [48] Treatment for First Cytomegalovirus Infection Post-Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With Valganciclovir (vol 78, pg 562, 2024)
    Papanicolao, Genovef A.
    Avery, Robin K.
    Cordonnie, Catherine
    Duarte, Rafael F.
    Haider, Shariq
    Maertens, Johan
    Peggs, Karl S.
    Solano, Carlos
    Young, Jo-Anne H.
    Fournier, Martha
    Murray, Rose Ann
    Wu, Jingyang
    Winston, Drew J.
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (03) : 803 - 803
  • [49] Cemiplimab Plus Chemotherapy Versus Chemotherapy Alone in Advanced NSCLC: 2-Year Follow-Up From the Phase 3 EMPOWER-Lung 3 Part 2 Trial (vol 18, pg 755, 2023)
    Mao, W.
    Chen, R.
    Zhang, J.
    Zheng, M.
    JOURNAL OF THORACIC ONCOLOGY, 2025, 20 (01) : 119 - 121
  • [50] Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma (vol 23, pg 133, 2005)
    McDermott
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) : 2877 - 2877
12345